CBL vs CGS

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CBL

CTRLBIONIC FPO [CBL]

53MEDIUM

CGS

COGSTATE FPO [CGS]

53MEDIUM

Score Breakdown

CBL CGS
Technical
77
62
Catalyst
50
50
Sentiment
50
50
Fundamental
55
95
Momentum
75
80
Risk Gate
50
50

Key Metrics

CBL Metric CGS
$23.9MMarket Cap$372.8M
247KAvg Volume (20d)89K
N/AShort Interest+0.0%
$0.08652-Week High$2.970
$0.02652-Week Low$1.210
+1.8%Daily Change+1.9%
$0.058Entry Price$2.150
-91.6%ROE+22.5%
-107.0%Profit Margin+19.2%

Active Signals

CBL Signals

●MACD momentum is picking up steam
●Above-average volume (1.9x) on a green day — buyers stepping up
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Low cash runway (3 quarters) - dilution risk
●Low P/S ratio (3.9x)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

CGS Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (6.6x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)

Ask Scout AI to compare CBL and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CBL Full Analysis → CGS Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).